Biology Of Blood And Marrow Transplantation

Biology Of Blood And Marrow Transplantation

血液和骨髓移植生物学

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Biology Of Blood And Marrow Transplantation》是由Elsevier Inc.出版社于1995年创办的英文国际期刊(ISSN: 1083-8791,E-ISSN: 1523-6536),该期刊长期致力于血液学领域的创新研究,主要研究方向为医学-免疫学。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA未开放获取模式(OA占比%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比0.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在0篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Biology Of Blood And Marrow Transplantation审稿周期约为 一般,3-6周 。该刊近年未被列入国际预警名单,年发文量约0篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 0 发文量

中科院分区

中科院 SCI 期刊分区 2021年12月旧的升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植
2区 2区 2区

中科院 SCI 期刊分区 2021年12月基础版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植
3区 3区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 27 / 79

66.5%

学科:IMMUNOLOGY SCIE Q3 85 / 161

47.5%

学科:TRANSPLANTATION SCIE Q2 7 / 26

75%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.6 SJR:1.748 SNIP:1.294
学科类别 分区 排名 百分位
大类:Medicine 小类:Hematology Q1 21 / 123

83%

大类:Medicine 小类:Transplantation Q1 8 / 36

79%

期刊发文

  • Comparable outcomes of first-line hematopoietic stem cell transplantation from unrelated and matched sibling donors in adult patients with aplastic anemia: A retrospective single-centre study

    Author: Yuping Zhang, Liangliang Wu, Wenjian Mo, Ming Zhou, Yumiao Li, Xiaowei Chen, Caixia Wang, Shiyi Pan, Shilin Xu, Wei Zhou, Ruiqing Zhou, Shunqing Wang

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, Vol., , DOI:10.1016/j.bbmt.2019.03.020

  • Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy

    Author: Tingting Pan, Jiaqian Qi, Tao You, Shiyu Han, Liping Yang, Wenjing Miao, Depei Wu, Changgeng Ruan, Li Zhu, Yue Han

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, Vol., , DOI:10.1016/j.bbmt.2019.03.002

  • Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study

    Author: Limin Liu, Shan Liu, Yanming Zhang, Huifen Zhou, Qingyuan Wang, Hong Tian, Feng Chen, Huiying Qiu, Xiaowen Tang, Yue Han, Chengcheng Fu, Zhengming Jin, Suning Chen, Aining Sun, Miao Miao, Depei Wu

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, Vol., , DOI:10.1016/j.bbmt.2019.02.024

  • Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

    Author: Jiasheng Wang, Yongxian Hu, Shuye Yang, Guoqin Wei, Xin Zhao, Wenjun Wu, Yanlei Zhang, Yafei Zhang, Donghe Chen, Zhao Wu, Lei Xiao, Alex Hongsheng Chang, He Huang, Kui Zhao

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, Vol., , DOI:10.1016/j.bbmt.2019.02.008

  • Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

    Author: Rui Ma, Xiao-Jun Huang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Chen-Hua Yan, Wei Han, Feng-Rong Wang, Yu-Hong Chen, Huan Chen, Yao Chen, Jing-Zhi Wang, Yu Wang

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, Vol., , DOI:10.1016/j.bbmt.2019.01.030

  • Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era

    Author: Yu-juan Xue, Yi-fei Cheng, Ai-dong Lu, Yu Wang, Ying-xi Zuo, Chen-hua Yan, Jun Wu, Yu-qian Sun, Pan Suo, Yu-hong Chen, Huan Chen, Yue-ping Jia, Kai-yan Liu, Wei Han, Lan-ping Xu, Le-ping Zhang, Xiao-jun Huang

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, Vol., , DOI:10.1016/j.bbmt.2018.12.007

  • FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation

    Author: Hong Wang, Tian-Tian Chu, Shi-Yu Han, Jia-Qian Qi, Ya-Qiong Tang, Hui-Ying Qiu, Cheng-Cheng Fu, Xiao-Wen Tang, Chang-Geng Ruan, De-Pei Wu, Yue Han

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, Vol., , DOI:10.1016/j.bbmt.2018.11.031

  • Occurrence and Severity of Donor Lymphocyte Infusion–Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

    Author: Wen-Jing Yu, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang

    Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, Vol., , DOI:10.1016/j.bbmt.2018.11.024